Jennerex Inc. Report issue

For profit Phase 2
Founded: San Francisco CA United States (2008)
Status: Acquired by SillaJen, Inc. (2014)

Organization Overview

First Clinical Trial
2008
NCT00629759
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Jennerex Biotherapeutics | Jennerex Biotherapeutics (Jennerex, Inc.)